TEACHERS ADVISORS, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 134 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$824,000
+11.8%
320,6140.0%0.00%0.0%
Q4 2018$737,000
-64.2%
320,614
-50.0%
0.00%0.0%
Q3 2018$2,058,000
+145.0%
641,228
+116.1%
0.00%0.0%
Q2 2018$840,000
-10.7%
296,791
+11.7%
0.00%0.0%
Q1 2018$941,000
-8.7%
265,7270.0%0.00%0.0%
Q4 2017$1,031,000
+78.4%
265,727
+16.8%
0.00%0.0%
Q3 2017$578,000
-28.7%
227,467
-23.5%
0.00%0.0%
Q2 2017$811,000
-12.0%
297,167
+6.7%
0.00%0.0%
Q1 2017$922,000
+81.5%
278,553
+30.6%
0.00%0.0%
Q4 2016$508,000
-18.3%
213,368
+26.0%
0.00%0.0%
Q3 2016$622,000
+98.7%
169,403
+20.8%
0.00%0.0%
Q2 2016$313,000
+16.8%
140,253
+8.9%
0.00%
Q1 2016$268,000
-31.3%
128,7320.0%0.00%
-100.0%
Q4 2015$390,000
+22.6%
128,7320.0%0.00%0.0%
Q3 2015$318,000
-23.0%
128,7320.0%0.00%0.0%
Q2 2015$413,000
-14.7%
128,732
-5.0%
0.00%0.0%
Q1 2015$484,000
+77.3%
135,515
+12.7%
0.00%0.0%
Q4 2014$273,000
+17.2%
120,2710.0%0.00%
Q3 2014$233,000
-46.7%
120,2710.0%0.00%
-100.0%
Q2 2014$437,000
-14.8%
120,271
-9.0%
0.00%0.0%
Q1 2014$513,000
+36.1%
132,1610.0%0.00%0.0%
Q4 2013$377,000
-11.1%
132,161
+11.5%
0.00%0.0%
Q3 2013$424,000
+7.1%
118,491
-0.0%
0.00%0.0%
Q2 2013$396,000118,5350.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders